Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation-2 (TELSTAR-2)
University of Twente
Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
Johns Hopkins University
Understanding and Treating Suicidal Ideation With Ketamine
The Royal's Institute of Mental Health Research
Psilocybin for Methamphetamine Addiction
Kevin Murnane
Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects
University Hospital, Basel, Switzerland
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)
Centre for Addiction and Mental Health
Tolerability of MDMA in Schizophrenia
Anya Bershad, MD, PhD
Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants
University Hospital, Basel, Switzerland
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
Grace Lim, MD, MS
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
Deepak C. D'Souza
Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers
MoCA Clinic and Institute
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN
Unity Health Toronto
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
Nicky Mehtani, MD, MPH
MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder
Stephen Robert Marder
Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs
University College, London
Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study
McMaster University
Pain Reduction for Limb Injuries in Pediatric Emergency Departments: Intranasal Fentanyl or Intranasal Ketamine vs Oral Morphine
Assistance Publique - Hôpitaux de Paris
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
Icahn School of Medicine at Mount Sinai
MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy for Veterans With Severe Posttraumatic Stress Disorder
Patricia Suppes
Intravenous Ketamine for Treatment-Resistant Depression
Mayo Clinic
Investigation of Psychedelic Effects in Psychoactive Substances
Johns Hopkins University
Non-steroidal Anti-inflammatory Drugs in Pleurodesis
Centre Hospitalier Universitaire, Amiens
State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma
Baylor College of Medicine
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
Definium Therapeutics US, Inc.
Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls
University Hospital, Basel, Switzerland
The ENHANCE Study: taVNS and Psilocybin
University of Wisconsin, Madison
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
Yale University
Pragmatic Trial of Psilocybin Therapy in Palliative Care
Charles S. Grob, M.D.
Psilocybin-Assisted Therapy for Physician Well-Being and Burnout
University of California, San Diego
Psilocybin rTMS for Treatment Resistant Depression
University of Texas at Austin
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
Icahn School of Medicine at Mount Sinai
Psychedelic-assisted Group Program for First Responders
Empower Research Inc
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Cybin IRL Limited
Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot Study
Unity Health Toronto
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest
Christian Hassager
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
Definium Therapeutics US, Inc.
Safety for Home Administration of Microdose Psilocybin Use
Johns Hopkins University
Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine
Insel Gruppe AG, University Hospital Bern
Modulation of the Inflammatory Response in Bariatric Surgery
Hospital HM Nou Delfos
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
University of Colorado, Denver
Study of Psilocybin for Anorexia in Young Adults
Marissa Raymond-Flesch, MD, MPH
MDMA-Assisted CBCT for PTSD vs CBCT RCT
Remedy
Veteran's Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-Life
Albany Research Institute, Inc.
Psilocybin-assisted Treatment for Cannabis Use Disorder
Johns Hopkins University
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
National Institute of Mental Health (NIMH)
Psilocybin for Treatment-Resistant Depression in Autism
Centre for Addiction and Mental Health
A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis
Novartis Pharmaceuticals
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.